Mechanical circulatory support as a bridge to cancer therapy in patients with end stage heart failure: a single center experience

Key Takeaways for GI Nurses

• Patients with mechanical circulatory support devices (such as LVADs or temporary mechanical support) may present to the GI lab for diagnostic or therapeutic procedures, requiring specialized knowledge of these complex cardiac devices and their implications for procedural planning
• Understanding the intersection of cardiac failure, oncology, and GI care is increasingly important as more patients survive with advanced heart failure while requiring cancer treatment that may involve GI procedures
• These high-acuity patients require enhanced monitoring capabilities and coordination between cardiology, oncology, and GI teams to ensure safe procedural outcomes
• Familiarity with anticoagulation management in mechanically supported patients is crucial, as these devices often require complex anticoagulation regimens that impact bleeding risk during endoscopic procedures

Clinical Relevance

As mechanical circulatory support technology advances and becomes more widely utilized, GI and endoscopy nurses will increasingly encounter patients with these devices requiring gastrointestinal procedures. These patients represent a unique population with complex medical needs that bridge multiple specialties. The management of such patients requires enhanced collaboration between nursing teams, as the presence of mechanical support devices significantly impacts procedural planning, sedation considerations, and post-procedure monitoring protocols.

From an operational standpoint, units caring for these patients must be prepared with appropriate monitoring equipment and staff educated in the basics of mechanical circulatory support device function. This includes understanding alarm systems, recognizing device malfunction signs, and knowing when to immediately involve cardiology or perfusion specialists. Additionally, these patients often require modified positioning during procedures and may have specific hemodynamic considerations that differ from standard GI patients.

The growing population of patients requiring bridging therapies for cancer treatment also highlights the importance of comprehensive care coordination. GI nurses play a vital role in ensuring these medically complex patients receive appropriate screening, diagnostic, and therapeutic endoscopic interventions while their cardiac status is optimized. This may include procedures for nutritional support, bleeding management, or oncologic evaluation that are essential components of their overall treatment plan.

Bottom Line

While this cardiac-focused research may seem outside the typical scope of GI nursing, it represents an emerging patient population that endoscopy units will increasingly encounter. GI nurses should familiarize themselves with the basics of mechanical circulatory support devices and develop protocols for managing these high-acuity patients, as the intersection of advanced heart failure management and cancer care often involves gastrointestinal procedures that require specialized nursing expertise and enhanced safety measures.